This article is more than 5 years old. Information may no longer be current.

VIDEO: Diabetes, obesity associated with chemotherapy-induced neuropathy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — Dawn L. Hershman, MD, MS, associate professor of medicine at Columbia University Medical Center, reviews study results that identified comorbidities and lifestyle-related factors that can predict chemotherapy-induced peripheral neuropathy risk at the ASCO Annual Meeting.

The researchers found that patients with diabetes demonstrated a twofold greater risk for chemotherapy-induced peripheral neuropathy. Further, obese patients were more likely to develop the toxicity, whereas patients who exercised regularly had a lower risk.

“This gives us clues into interventions that may be useful and have not been studied well in terms of the prevention of this side effect,” Hershman said.